ArticleThe oncologist2023

Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy.

Valerie Gunchick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.